iBio, Inc.IBIONYSE
Loading
Cost of Revenue Over TimeStable
Percentile Rank80
5Y CAGR-18.4%
Studio
Year-over-Year Change

Direct costs attributable to producing goods sold

5Y CAGR
-18.4%/yr
Long-term compound
Percentile
P80
Within normal range
vs 5Y Ago
0.4x
Contraction
Streak
1 yr
Consecutive growthStable
PeriodValueYoY Change
TTM$530000.00-
2025$0.00-
2024$0.00-
2023$0.00-100.0%
2022$3.79M+159.3%
2021$1.46M+108.0%
2020$703000.00-
2019$0.00-
2018$0.00-
2017$0.00-